
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4950011
[patent_doc_number] => 20080306137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING DOCETAXEL AND METHODS FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/194609
[patent_app_country] => US
[patent_app_date] => 2008-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5287
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306137.pdf
[firstpage_image] =>[orig_patent_app_number] => 12194609
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/194609 | Pharmaceutical compositions comprising docetaxel and methods for preparation thereof | Aug 19, 2008 | Issued |
Array
(
[id] => 9530221
[patent_doc_number] => 08754094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Methods for heat shock protein dependent cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 12/673397
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 53
[patent_no_of_words] => 21415
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673397 | Methods for heat shock protein dependent cancer treatment | Aug 14, 2008 | Issued |
Array
(
[id] => 5324265
[patent_doc_number] => 20090062255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'TUMOR-TARGETING EVALUATION METHODOLOGY AND COMPOUNDS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/192595
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 46178
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062255.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192595 | TUMOR-TARGETING EVALUATION METHODOLOGY AND COMPOUNDS RELATED THERETO | Aug 14, 2008 | Abandoned |
Array
(
[id] => 7501721
[patent_doc_number] => 20110263592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/673463
[patent_app_country] => US
[patent_app_date] => 2008-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 37846
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263592.pdf
[firstpage_image] =>[orig_patent_app_number] => 12673463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673463 | Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Aug 13, 2008 | Issued |
Array
(
[id] => 5564767
[patent_doc_number] => 20090137620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'USE OF GALLIUM(III) COMPLEXES FOR THE TREATMENT OF MELANOMAS'
[patent_app_type] => utility
[patent_app_number] => 12/190759
[patent_app_country] => US
[patent_app_date] => 2008-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2673
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12190759
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/190759 | Use of gallium(III) complexes for the treatment of melanomas | Aug 12, 2008 | Issued |
Array
(
[id] => 5441897
[patent_doc_number] => 20090093536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING THIACREMONONE FOR PREVENTING OR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/186534
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6560
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12186534
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/186534 | Pharmaceutical composition comprising thiacremonone for treating colon cancer | Aug 5, 2008 | Issued |
Array
(
[id] => 5361596
[patent_doc_number] => 20090036390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/183007
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13619
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036390.pdf
[firstpage_image] =>[orig_patent_app_number] => 12183007
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/183007 | Compositions and methods for treating neoplastic diseases | Jul 29, 2008 | Issued |
Array
(
[id] => 4792822
[patent_doc_number] => 20080293796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Parenteral and oral formulations of benzimidazoles'
[patent_app_type] => utility
[patent_app_number] => 12/220364
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 22692
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12220364
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/220364 | Parenteral and oral formulations of benzimidazoles | Jul 23, 2008 | Abandoned |
Array
(
[id] => 8227277
[patent_doc_number] => 20120141479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/670053
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 56624
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670053
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670053 | Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors | Jul 22, 2008 | Abandoned |
Array
(
[id] => 6320467
[patent_doc_number] => 20100196365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS'
[patent_app_type] => utility
[patent_app_number] => 12/668083
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4132
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196365.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668083
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668083 | USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS | Jul 22, 2008 | Abandoned |
Array
(
[id] => 5507948
[patent_doc_number] => 20090081155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Use of Inhibitors of Indoleamine-2,3-Dioxygenase in Combination with Other Therapeutic Modalities'
[patent_app_type] => utility
[patent_app_number] => 12/175538
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20436
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081155.pdf
[firstpage_image] =>[orig_patent_app_number] => 12175538
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/175538 | Pharmaceutical compositions containing 1-methyl-D-tryptophan | Jul 17, 2008 | Issued |
Array
(
[id] => 4860500
[patent_doc_number] => 20080269350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'ST104P, AN ANTI-ANGIOGENIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/172948
[patent_app_country] => US
[patent_app_date] => 2008-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7376
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269350.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172948 | ST104P, an anti-angiogenic agent | Jul 13, 2008 | Issued |
Array
(
[id] => 7523115
[patent_doc_number] => 08026271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Formulations of indol-3-yl-2-oxoacetamide compounds'
[patent_app_type] => utility
[patent_app_number] => 12/171515
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4120
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026271.pdf
[firstpage_image] =>[orig_patent_app_number] => 12171515
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/171515 | Formulations of indol-3-yl-2-oxoacetamide compounds | Jul 10, 2008 | Issued |
Array
(
[id] => 4852587
[patent_doc_number] => 20080318330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Method of standardization of bacterial polysaccharides found in rumen fluid'
[patent_app_type] => utility
[patent_app_number] => 12/217542
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4532
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217542
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217542 | Method of standardization of bacterial polysaccharides found in rumen fluid | Jul 7, 2008 | Abandoned |
Array
(
[id] => 5343273
[patent_doc_number] => 20090181923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Method of increasing weight gain and reducing diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics'
[patent_app_type] => utility
[patent_app_number] => 12/217554
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5801
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181923.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217554
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217554 | Method of increasing weight gain and reducing diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics | Jul 7, 2008 | Abandoned |
Array
(
[id] => 5342271
[patent_doc_number] => 20090180921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Method of collecting, processing, sterilizing and stabilizing rumen fluid and the contained bacterial polysaccharides'
[patent_app_type] => utility
[patent_app_number] => 12/217553
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5830
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20090180921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217553 | Method of collecting, processing, sterilizing and stabilizing rumen fluid and the contained bacterial polysaccharides | Jul 7, 2008 | Abandoned |
Array
(
[id] => 5342472
[patent_doc_number] => 20090181122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Method of producing bacterial polysaccharides in rumen fluid'
[patent_app_type] => utility
[patent_app_number] => 12/217544
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4606
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217544 | Method of producing bacterial polysaccharides in rumen fluid | Jul 7, 2008 | Abandoned |
Array
(
[id] => 5342707
[patent_doc_number] => 20090181357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Method of freeze-drying sterilized rumen fluid to maintain the bioactivity of the bacterial polysaccharides'
[patent_app_type] => utility
[patent_app_number] => 12/217543
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4270
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217543 | Method of freeze-drying sterilized rumen fluid to maintain the bioactivity of the bacterial polysaccharides | Jul 7, 2008 | Abandoned |
Array
(
[id] => 8294494
[patent_doc_number] => 08222284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Stable formulations of thiadiazole derivative'
[patent_app_type] => utility
[patent_app_number] => 12/665740
[patent_app_country] => US
[patent_app_date] => 2008-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2697
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665740
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665740 | Stable formulations of thiadiazole derivative | Jul 6, 2008 | Issued |
Array
(
[id] => 5472958
[patent_doc_number] => 20090246124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'HIGH AFFINITY VEGF-RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/166042
[patent_app_country] => US
[patent_app_date] => 2008-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 22801
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246124.pdf
[firstpage_image] =>[orig_patent_app_number] => 12166042
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/166042 | High affinity VEGF-receptor antagonists | Jun 30, 2008 | Issued |